- Home
- PRTS vs QNCX Comparison
PRTS vs QNCX Comparison
Compare PRTS & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- QNCX
- Stock Information
- Founded
- PRTS 1995
- QNCX 2012
- Country
- PRTS United States
- QNCX United States
- Employees
- PRTS N/A
- QNCX N/A
- Industry
- PRTS Auto & Home Supply Stores
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRTS Consumer Discretionary
- QNCX Health Care
- Exchange
- PRTS Nasdaq
- QNCX Nasdaq
- Market Cap
- PRTS 47.8M
- QNCX 44.0M
- IPO Year
- PRTS 2007
- QNCX 2019
- Fundamental
- Price
- PRTS $0.91
- QNCX $0.95
- Analyst Decision
- PRTS Buy
- QNCX Strong Buy
- Analyst Count
- PRTS 3
- QNCX 5
- Target Price
- PRTS $1.60
- QNCX $8.00
- AVG Volume (30 Days)
- PRTS 527.5K
- QNCX 536.2K
- Earning Date
- PRTS 05-13-2025
- QNCX 05-13-2025
- Dividend Yield
- PRTS N/A
- QNCX N/A
- EPS Growth
- PRTS N/A
- QNCX N/A
- EPS
- PRTS N/A
- QNCX N/A
- Revenue
- PRTS $588,846,000.00
- QNCX N/A
- Revenue This Year
- PRTS $1.27
- QNCX N/A
- Revenue Next Year
- PRTS $6.16
- QNCX N/A
- P/E Ratio
- PRTS N/A
- QNCX N/A
- Revenue Growth
- PRTS N/A
- QNCX N/A
- 52 Week Low
- PRTS $0.68
- QNCX $0.51
- 52 Week High
- PRTS $1.45
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- PRTS 52.36
- QNCX 32.57
- Support Level
- PRTS $0.80
- QNCX $0.98
- Resistance Level
- PRTS $1.05
- QNCX $1.06
- Average True Range (ATR)
- PRTS 0.07
- QNCX 0.09
- MACD
- PRTS 0.00
- QNCX -0.00
- Stochastic Oscillator
- PRTS 44.00
- QNCX 7.08
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.